James Martin

594 total citations
21 papers, 363 citations indexed

About

James Martin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, James Martin has authored 21 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in James Martin's work include Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). James Martin is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). James Martin collaborates with scholars based in United States, Canada and Australia. James Martin's co-authors include Esteban Cvitkovic, Willet F. Whitmore, Joseph T. Spaulding, Lori J. Goldstein, Elizabeth A. Handorf, Alberto J. Montero, John E. Ubelaker, Hong Wu, Stefan K. Barta and Jérry Y. Niederkorn and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

James Martin

19 papers receiving 337 citations

Peers

James Martin
Kellie L. Bodeker United States
N. Anderson United States
F. Elferink Netherlands
Thomas Budd United States
Guifeng Liu China
Hiromasa Sakamoto Japan
Edith A. Perez United States
Marta Morawska Poland
Maria O. Vannozzi Italy
Kellie L. Bodeker United States
James Martin
Citations per year, relative to James Martin James Martin (= 1×) peers Kellie L. Bodeker

Countries citing papers authored by James Martin

Since Specialization
Citations

This map shows the geographic impact of James Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Martin more than expected).

Fields of papers citing papers by James Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Martin. The network helps show where James Martin may publish in the future.

Co-authorship network of co-authors of James Martin

This figure shows the co-authorship network connecting the top 25 collaborators of James Martin. A scholar is included among the top collaborators of James Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Martin. James Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serbulea, Vlad, James Martin, & Gary K. Owens. (2025). Role of Diverse Smooth Muscle Cell Phenotypic Transitions in Atherosclerosis Development and Late-Stage Pathogenesis. Annual Review of Physiology. 88(1). 345–370.
2.
Kharouta, Michael, Eleanor Harris, Robert Shenk, et al.. (2023). Reduced-Dose Radiation Therapy and Concurrent Paclitaxel Chemotherapy in Lymph Node-Positive Breast Cancer: Long-Term Follow-up of a Single-Institution Prospective Study. International Journal of Radiation Oncology*Biology*Physics. 117(4). 883–886.
3.
Caimi, Paolo F., Koen van Besien, James Martin, et al.. (2023). Development and Clinical Validation of an Ultra-Fast CAR-T Manufacturing Platform Enabling Production of CAR-T Cells in Less Than 1 Day. Blood. 142(Supplement 1). 4848–4848. 6 indexed citations
4.
Martin, James, Elizabeth A. Handorf, Alberto J. Montero, & Lori J. Goldstein. (2022). Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data. The Oncologist. 27(6). 441–446. 29 indexed citations
5.
6.
Ishii, Yumiko, et al.. (2019). Leukotriene C4 synthase deficiency causes spontaneous emphysematous changes in mice. PA5412–PA5412. 1 indexed citations
7.
Martin, James & Lori J. Goldstein. (2018). Profile of abemaciclib and its potential in the treatment of breast cancer. OncoTargets and Therapy. Volume 11. 5253–5259. 29 indexed citations
8.
Martin, James, Hong Wu, & Stefan K. Barta. (2018). CD30+ T-cell lymphoproliferative disorders. Chinese Clinical Oncology. 8(1). 4–4. 9 indexed citations
9.
Martin, James, et al.. (2018). Rash and subcutaneous fat necrosis after DEB-TACE with doxorubicin. BMJ Case Reports. 2018. bcr–2017. 5 indexed citations
10.
Allard, Benoît, Erwan Pernet, Jeffrey Downey, Maziar Divangahi, & James Martin. (2018). Adaptation to oxidative stress induced-lung injury: friend or foe of influenza infection?. PA2658–PA2658. 1 indexed citations
11.
Liu, Yang, Chethan Ramamurthy, Asya Varshavsky, et al.. (2017). End-of-life (EOL) care in medical oncology fellows' clinics.. Journal of Clinical Oncology. 35(31_suppl). 75–75. 1 indexed citations
12.
Martin, James & Eric S. Winer. (2015). Genomics in acute myeloid leukemia: from identification to personalization.. PubMed. 98(11). 27–30. 1 indexed citations
13.
McGovern, Toby K., Muhannad Hassan, William S. Powell, et al.. (2010). AEOL10150: A Novel Therapeutic For Rescue Treatment Following Toxic Gas Lung Injury. A6354–A6354. 1 indexed citations
14.
15.
16.
Niederkorn, Jérry Y., John E. Ubelaker, & James Martin. (1990). Vascularization of corneas of hairless mutant mice.. PubMed. 31(5). 948–53. 8 indexed citations
17.
Moldofsky, Harvey, James Martin, Charles Walter, et al.. (1985). Sleep-Promoting Material Extracted from Peritoneal Dialysate of Patients with End-Stage Renal Disease and Insomnia. Peritoneal Dialysis International. 5(3). 189–193. 10 indexed citations
18.
Cvitkovic, Esteban, et al.. (1977). Improvement of Cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model. Cancer. 39(4). 1357–1361. 197 indexed citations
19.
Martin, James, et al.. (1965). Generation of Methylene by Photolysis of Hydrocarbons. Journal of the American Chemical Society. 87(12). 2763–2765. 38 indexed citations
20.
Martin, James, et al.. (1965). Osteogenic Sarcoma of the Kidney: Report of a Case. The Journal of Urology. 94(5). 532–535. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kellie L. Bodeker Breakdown of academic impact, for papers by N. Anderson Breakdown of academic impact, for papers by F. Elferink Breakdown of academic impact, for papers by Thomas Budd Breakdown of academic impact, for papers by Guifeng Liu Breakdown of academic impact, for papers by Hiromasa Sakamoto Breakdown of academic impact, for papers by Edith A. Perez Breakdown of academic impact, for papers by Marta Morawska Breakdown of academic impact, for papers by Maria O. Vannozzi
Rankless by CCL
2026